Futura Medical Share Discussion Threads

[lbo] 03/8/2022 13:51

And it still has no patent either!? Anyone can make a similar alcohol and water cooling gel themselves and claim it works by evaporative cooling. What a pump and soon to be dumped ˜swindle’ by the rampers!






The composition of the invention contained: ethanol: 33%; water: 35%; glycerol: 24%; propylene glycol: 6%; Carbopol® Ultrez 10: 1%. pH was adjusted to 5.25 with potassium hydroxide solution. The ethanol used in the manufacture of the composition was absolute ethanol (i.e. 100% ethanol free from water) such that the final composition contained 33% of pure ethanol. If a lower grade of ethanol was used which contained impurity amounts of water (e.g. 96% ethanol), then the amount used would have to be adjusted to ensure the final composition contained the correct amount of the components, i.e. 33% pure ethanol and 35% water.





Voltaren vehicle gel is the carrier substance of the topical Voltaren products. This vehicle gel is especially formulated to be easily applied on the skin, while providing some sensory benefits. The present study aims to substantiate the widely perceived hydrating and cooling effect of Voltaren vehicle

[blackbear] 03/8/2022 13:27

get on this train choo choo...

[j777j] 03/8/2022 13:26

Up she goes again


Short squeeze continues


See you back in the 80's

[lbo] 03/8/2022 13:20

Get ready for the next dump after the rampers pump! LOL

[j777j] 03/8/2022 12:54

US trial was an open study so likely management have pretty good idea already


Up up and away as short squeeze continues

[broomrigg] 03/8/2022 12:22

Nice move today (so far at least) :-)

Where has that demented LBO gone?!

[blackbear] 03/8/2022 12:19

News will come soon enough, 70p is a starter by christmas imho..

[losses] 03/8/2022 12:09

Burn LBO burn baby... we need a big woosh to get rid of him... like going back to 70p

[glavey] 03/8/2022 04:53

Must be because of the newsflow... Oh, there isn't any.

[j777j] 02/8/2022 22:22

LBO is just a psychopathic liar.

All those posts wasting his own time.


Up she goes again 100p and beyond

[lbo] 02/8/2022 15:23

Imagine anyone can make their own alcohol and water gel and solve all the mild to moderate ED in the world! LOL



GlaxoSmithKline unexpectedly handed back the development rights to Futuras erectile dysfunction gel. We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK said.



The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.


Dermasys on its own has no patent anymore. Even the Dermasys trademark predates by many years the umbrella patents covering MED2005 (Dermasys and GTN) and TPR100 (Dermasys and Diclofenac) which are all expiring soon also.

from Trinity in a previous note regarding the MED2005 patent:

the long development period resulted in a material erosion of the patent life, with the original formulation patent expected to expire in 2025

Dermasys is even older so is off patent

2002 plus 20 years = 2022



The DermaSys(R) technology was originally developed by Futura for use in the Company's topical treatment for erectile dysfunction, MED2002





Under the terms of the agreement, Thornton & Ross will conduct the manufacturing scale-up of TPR100 and hold rights to manufacture, market and distribute the product in the UK for the lifetime of the product's patents, which run to at least 2028 in the UK

[j777j] 02/8/2022 10:10

75% of the ED markeplace is mild to moderate


300 million men suffer ED

So 75% of that gives Fum a potential marketplace of 225 million men

At £5 a dose even a meagre 10% market share would bring in £112 million if they only took one dose a year


Imagine twice a week!!!!!

[j777j] 02/8/2022 10:07

Consumer In-Use Test

Cooper, as part of its due diligence process, conducted a consumer marketing Home Use Test ("HUT") in the United Kingdom, France and the Netherlands whereby individuals self-diagnosed with ED were provided with a four-pack sample of MED3000. The in-use results were in line with findings published in 2019 in Futura's clinical study FM57 which showed that over two thirds of patients experienced a clinically meaningful benefit from using MED3000 in a controlled clinical setting. MED3000 performed well in the real world, consumer HUT setting, with the majority of men with ED, other than men suffering from severe ED with significant co-morbidities, seeing an improvement in erectile performance and underlining the product's potential as a highly effective, safe, clinically proven, topical treatment for ED.

[j777j] 02/8/2022 10:05

Up she goes again

Current broker price target av 95p

3X plus returns on the table

[j777j] 02/8/2022 08:44

Amber Heard Lawyers Claimed Johnny Depp Had Erectile Dysfunction That Likely Made Him 'Angry' (Report)








All fantastic PR for the worlds first topically applied OTC ED product

[j777j] 02/8/2022 08:38

Just days away now


"The US remains the largest market opportunity globally for ED treatments OTC

The Company remains on track to be able to disclose the results in early September."

[glavey] 02/8/2022 03:18

What are bagholders in for this time, another raise?

[j777j] 01/8/2022 15:54

Up she goes.Not too late to 3x plus your money

[lbo] 01/8/2022 15:32

Where did they say they would be fully publishing the results of FM71 for peer review? They didn't ever fully publish FM57 for peer review.

[kemche] 01/8/2022 14:28

J7, Have you sold your CHLL?

[j777j] 01/8/2022 14:25

Max 6 weeks until US results published


3X to well over 5X potential upside here